Translocation of bacteria from the gastrointestinal tract: protection afforded by lisofylline.
Translocation of bacteria from the gastrointestinal tract: protection afforded by lisofylline.
复制标题
细菌从胃肠道的移位:利索茶碱提供的保护。
DOI:
10.1016/s0041-1345(98)01561-9
复制
发表时间:
1999
影响因子:
0.9
通讯作者:
Starzl,TE
中科院分区:
文献类型:
--
作者:
Cicalese,L;Yacoub,W;Rogers,J;Fung,JJ;Rao,AS;Starzl,TE
MATERIALS AND METHODSMale ACI rats weighing 200 to 250 g (Harlan Sprague Dawley) were used for the study. The small bowel (SB) was rendered ischemic by aseptically clamping the superior mesenteric artery for 30 and 45 minutes while the animals were kept euthermic (37 C). The SB was reperfused and the abdomen was sutured. Blood, mesenteric lymph nodes (MLN), spleen, liver, lung, and pancreas specimens were collected 24 hours after surgery for quantitative and qualitative microbiologic analysis. Peritoneal swab cultures were performed at the time of laparotomy (control), at the end of surgery before abdominal closure (contamination control), and at sacrifice. LSF (25 mg/kg) was administered intravenously (IV) in the study groups before and after the insult while control animals received equal volume of sterile saline. Translocation of fluorescent latex microspheres, administered to the rats 24 hours before experimentation in drinking water, was used to confirm the intestinal origin of translocating particles and was assessed by fluorescent-activated cell sorter on peritoneal lavages. SB mucosal changes were also assessed by histopathological analysis. Sham untreated animals were used as controls (n= 6). The effect of LSF alone was tested on undamped animals (n= 4) while the effect of 30 and 45 minutes of intestinal ischemia on BT was evaluated between untreated (n= 6; n= 10, respectively) and LSF-treated rats (n= 6; n= 9, respectively). Fisher Exact Test was used to compare the proportions of positive cultures and a P value of less than. 05 was considered statistically significant.RESULTSThe data summarized in Table 1 is expressed as a percentage of animals with positive organ cultures for Erischeria-coli and/or enterococcus (> 1× 10 4 bacteria) or peritoneal swabs with more than 300 colonies (P<. 05).